Literature DB >> 9745418

Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency.

G I Baroncelli1, S Bertelloni, C Ceccarelli, G Saggese.   

Abstract

The effect of anthropometric variables and bone size on bone mineral density (BMD) was examined in 22 children with GH deficiency (GHD) aged 6.1-8.0 yr at diagnosis and in 40 sex- and chronological age-matched controls. In all patients and controls, bone mineral content (BMC), BMDarea and BMD corrected for the apparent bone volume (BMDvolume) were measured by dual-energy x-ray absorptiometry in the lumbar spine at L2-L4 level. In patients, BMDarea was corrected for body height (BMDheight), body mass index (BMDBMI), and bone age (BMDBA). Patients showed significantly reduced (P < 0.0001) BMC (males 11.55 +/- 0.71 g, females 10.13 +/- 1.48 g) and BMDarea (males 0.502 +/- 0.033 g/cm2, females 0.515 +/- 0.034 g/cm2) compared with controls (BMC: males 18.09 +/- 1.23 g, females 15.58 +/- 1.87 g; BMDarea: males 0.689 +/- 0.065 g/cm2, females 0.685 +/- 0.059 g/cm2). In patients, BMDheight (males 0.537 +/- 0.031 g/cm2, females 0.548 +/- 0.032 g/cm2) and BMDBMI (males 0.641 +/- 0.028 g/cm2, females 0.624 +/- 0.035 g/cm2) remained significantly lower (P < 0.02 to P < 0.0001) than BMDarea of controls. BMDBA of patients was significantly reduced (-1.49 +/- 0.51 Z score, P < 0.0001) in comparison with bone age-matched controls (n = 35). BMDvolume was significantly lower (P < 0.01 to P < 0.0005) in patients (males 0.268 +/- 0.006 g/cm3, females 0.276 +/- 0.010 g/cm3) compared with chronological age-matched controls (males 0.283 +/- 0.013 g/cm3, females 0.293 +/- 0.017 g/cm3). Mean bone volume of patients was affected to a greater extent than bone area (-2.36 +/- 0.49 Z score and -1.56 +/- 0.70 Z score, respectively). Bone area/bone volume ratio was significantly higher in patients than in chronological age-matched controls (0.53 +/- 0.02 and 0.42 +/- 0.08, P < 0.0001, respectively). Chronological age, body height, BMI, and bone age correlated significantly with BMDarea (r2 = 0.389-0.450, P < 0.002 to P < 0.001) but not with BMDvolume (P = not significant). The results show that anthropometric variables and bone size affect lumbar BMC and BMDarea in children with GHD. Reduced lumbar BMDvolume indicates that apparent true bone density is decreased in children with GHD, suggesting a role of GH in bone mineralization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745418     DOI: 10.1210/jcem.83.9.5072

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  The effect of growth hormone deficiency on size-corrected bone mineral measures in pre-pubertal children.

Authors:  M Gahlot; R Khadgawat; R Ramot; M Eunice; A C Ammini; N Gupta; M Kalaivani
Journal:  Osteoporos Int       Date:  2011-11-10       Impact factor: 4.507

Review 2.  Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.

Authors:  G Saggese; G I Baroncelli; T Vanacore; L Fiore; S Ruggieri; G Federico
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

3.  Reference values of bone stiffness index and C-terminal telopeptide in healthy European children.

Authors:  D Herrmann; T Intemann; F Lauria; S Mårild; D Molnár; L A Moreno; I Sioen; M Tornaritis; T Veidebaum; I Pigeot; W Ahrens
Journal:  Int J Obes (Lond)       Date:  2014-09       Impact factor: 5.095

4.  Recombinant growth hormone treatment, osteoporosis and fractures, more complicated than it seems!

Authors:  Maria Fleseriu
Journal:  Endocrine       Date:  2018-01-19       Impact factor: 3.633

5.  Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients.

Authors:  Giampiero I Baroncelli; Francesco Vierucci; Silvano Bertelloni; Paola Erba; Elisa Zampollo; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2013-04-03       Impact factor: 2.626

6.  Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults.

Authors:  I M van der Sluis; M A J de Ridder; A M Boot; E P Krenning; S M P F de Muinck Keizer-Schrama
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

7.  Enhanced effect of zinc and calcium supplementation on bone status in growth hormone-deficient children treated with growth hormone: a pilot randomized controlled trial.

Authors:  Veena Ekbote; Anuradha Khadilkar; Shashi Chiplonkar; Zulf Mughal; Vaman Khadilkar
Journal:  Endocrine       Date:  2012-12-09       Impact factor: 3.633

8.  Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.

Authors:  Nelly Mauras; Lilliam Gonzalez de Pijem; Helen Y Hsiang; Paul Desrosiers; Robert Rapaport; I David Schwartz; Karen Oerter Klein; Ravinder J Singh; Anna Miyamoto; Kim Bishop
Journal:  J Clin Endocrinol Metab       Date:  2007-12-28       Impact factor: 5.958

Review 9.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

10.  Bone quality assessed by phalangeal quantitative ultrasonography in children and adolescents with isolated idiopathic growth hormone deficiency.

Authors:  M Vignolo; E Di Battista; A Parodi; C Torrisi; F De Terlizzi; G Aicardi
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.